June 11, 2021
Ravi Samy, MD, professor in the University of Cincinnati College of Medicine and chief of the UC Division of Otology/Neurotology, spoke with Ivanhoe Broadcasting for a segment about a new implant designed to help hearing impaired patients.
December 10, 2021
Parosmia is a post-COVID-19 condition that can make once-pleasant foods and scents smell and taste disgusting, in some instances like sewage, garbage or smoke. The condition is being reported in increasing numbers. HuffPost published a story on parosmia, citing the case of a 20-year-old woman who has posted several TikTok videos on her experiences with the condition. One of the experts cited in the article is Ahmad Sedaghat, MD, PhD, associate professor and director of the Division of Rhinology, Allergy and Anterior Skull Base Surgery in the UC College of Medicine.
April 15, 2021
Rebecca Howell, MD, of the Department of Otolaryngology-Head and Neck Surgery in the UC College of Medicine, was interviewed by WXIX-TV, Fox19 about World Voice Day coming up on Friday, April 16.
September 23, 2021
Ahmad Sedaghat, MD, University of Cincinnati Director of Rhinology, Allergy and Anterior skull base surgery, and associate professor of otolaryngology was interviewed by CNBC for a story on parosmia, a side effect of COVID-19 that distorts a person's sense of smell.
March 17, 2021
Charles Prestigiacomo, MD, created the Advanced Anatomy of the Head and Neck elective, offered to fourth-year students at the UC College of Medicine who are getting ready to match in surgical residencies and begin performing procedures on patients. He and colleagues are seeing how this class is better preparing students to begin their careers with a little more “real-life” practice.
January 9, 2024
A new trial at the University of Cincinnati Gardner Neuroscience Institute, funded by a $660,000 National Institutes of Health (NIH) grant, will test an at-home tongue endurance exercise to improve patients’ swallowing function after a stroke.
September 7, 2022
University of Cincinnati researchers recently published study results in JAMA Otolaryngology showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.
March 26, 2021
Katie Phillips, MD, an associate professor in the University of Cincinnati College of Medicine, discusses spring's arrival with allergies in tow. Pollenating trees in the Tristate are making some resident miserable with itchy eyes, runny noses and congestion.
February 26, 2024
According to the National Institutes for Health, chronic sinusitis, also known as chronic rhinosinusitis (CRS), affects approximately 14.6% of the United States population and is currently the fifth most common condition treated with antibiotics, accounting for up to 22 million physician visits and costing as much as $5 billion annually. New research from the University of Cincinnati examines the incidence of people suffering from allergy symptoms who actually have CRS, a finding that could impact how those symptoms are treated. The research was published in the journal Otolaryngology - Head and Neck Surgery.
September 15, 2022
HealthDay highlighted recent University of Cincinnati research that found administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.